Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $34.90 and last traded at $34.43, with a volume of 1615129 shares. The stock had previously closed at $34.50.
Wall Street Analysts Forecast Growth
ACHC has been the topic of a number of analyst reports. Guggenheim lifted their price objective on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. Barclays increased their target price on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. Cantor Fitzgerald raised their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. KeyCorp upped their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Finally, TD Cowen raised their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus price target of $28.69.
Check Out Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the prior year, the firm earned $0.40 earnings per share. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.
Institutional Trading of Acadia Healthcare
Large investors have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of Acadia Healthcare by 1.5% during the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after purchasing an additional 668 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Acadia Healthcare by 0.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after purchasing an additional 696 shares in the last quarter. Treasurer of the State of North Carolina raised its holdings in shares of Acadia Healthcare by 2.1% during the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after purchasing an additional 867 shares in the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in shares of Acadia Healthcare by 2.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after purchasing an additional 867 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Read More
- Five stocks we like better than Acadia Healthcare
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
